Risk Prediction for Adverse Events during Initiation of Sotalol and Dofetilide for the Treatment of...
Risk Prediction for Adverse Events during Initiation of Sotalol and Dofetilide for the Treatment of Atrial Fibrillation
About this item
Full title
Author / Creator
Publisher
United States: Blackwell Publishing Ltd
Journal title
Language
English
Formats
Publication information
Publisher
United States: Blackwell Publishing Ltd
Subjects
More information
Scope and Contents
Contents
Background
Inpatient antiarrhythmic drug initiation for atrial fibrillation is mandated for dofetilide (DF) and is often performed for sotalol (SL), particularly if proarrhythmia risk factors are present. Whether low‐risk patients can be identified to safely allow outpatient initiation is unknown.
Methods
A single‐center retrospective coho...
Alternative Titles
Full title
Risk Prediction for Adverse Events during Initiation of Sotalol and Dofetilide for the Treatment of Atrial Fibrillation
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_crossref_primary_10_1111_pace_12586
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1111_pace_12586
Other Identifiers
ISSN
0147-8389
E-ISSN
1540-8159
DOI
10.1111/pace.12586
